Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

KNSA holding history

Kiniksa Pharmaceuticals International, plc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KNSA overviewAll 13F holders of KNSAFull Q2 2026 holdings

Shares (Q2 2026)
45,174
Value
$2.89M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of KNSA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202645,174$2.89M<0.1%−24,526−35.2%ReducedHolders
Q1 202669,700$3.36M<0.1%−8,216−10.5%ReducedHolders
Q4 202577,916$3.21M<0.1%+28,099+56.4%AddedHolders
Q3 202549,817$1.93M<0.1%+19,201+62.7%AddedHolders
Q2 202530,616$847.1K<0.1%−19,373−38.8%ReducedHolders
Q1 202549,989$1.11M<0.1%−8,609−14.7%ReducedHolders
Q4 202458,598$1.16M<0.1%+9,091+18.4%AddedHolders
Q3 202449,507$1.24M<0.1%+49,507NewHolders
Q2 20240$00.0%−104,762−100.0%Sold outHolders
Q1 2024104,762$2.07M<0.1%+19,346+22.6%AddedHolders
Q4 202385,416$1.50M<0.1%+22,602+36.0%AddedHolders
Q3 202362,814$1.09M<0.1%+18,171+40.7%AddedHolders
Q2 202344,643$628.6K<0.1%−6,672−13.0%ReducedHolders
Q1 202351,315$552.1K<0.1%−5,790−10.1%ReducedHolders
Q4 202257,105$855.4K<0.1%+57,105NewHolders
Q2 20220$00.0%−1,173−100.0%Sold outHolders
Q1 20221,173$12.0K<0.1%−75,302−98.5%ReducedHolders
Q4 202176,475$900.0K<0.1%−6,262−7.6%ReducedHolders
Q3 202182,737$942.0K<0.1%+62,718+313.3%AddedHolders
Q2 202120,019$279.0K<0.1%−15,624−43.8%ReducedHolders
Q1 202135,643$660.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.